The synergistic activity of vascular endothelial growth factor with IL-8 creates an immunosuppressive TME, favouring tumour growth and less accessibility of the ingress of immune effector cells to enter the tumour and thus eliminate tumour cells [139]. The gene discussed is CXCL8; the disease is neoplasm.